CS Diagnostics Corp. Launches Regulation D, Rule 506(c) Investment Offering
Accessnewswireยท2025-10-13 11:30
CHEYENNE, WYOMING / ACCESS Newswire / October 13, 2025 / CS Diagnostics Corp. (OTCQB:CSDX) today announced the official launch of its Regulation D, Rule 506(c) investment offering (the "Offering"), marking an important milestone in the company's ongoing mission to enhance patient safety and health outcomes through advanced medical technologies. CS Diagnostics Corp. is a global medical technology company dedicated to innovation in healthcare safety and performance. ...